Crinetics Pharmaceuticals CRNX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's EV / sales?
- Crinetics Pharmaceuticals (CRNX) reported EV / sales of 206.7× in Q1 2026.
- How has Crinetics Pharmaceuticals's EV / sales changed year-over-year?
- Crinetics Pharmaceuticals's EV / sales decreased by 94.9% year-over-year, from 4,047.1× to 206.7×.
- What is the long-term trend for Crinetics Pharmaceuticals's EV / sales?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's EV / sales has grown at a -14.7% compound annual growth rate (CAGR), from 1,069.4× to 567×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.